The first investor for technical founders in bio.
Amplify Bio is the first investor for a new generation of technical founders in the life sciences, backing them from the earliest stages as they build the digital platforms and infrastructure necessary to accelerate biological progress.
Our CompaniesOur Manifesto
We are in the age of Digital Biology – software and AI are starting to transform science. Modern life science labs have become some of the largest data generators on the planet. A new generation of technical founders, equally fluent in compute and biology, is leading this revolution; we’re building Amplify Bio to support them from day one.
Read the ManifestoWriting

Waypoint Bio: Immune Engineering
Announcing Waypoint Bio's $20M Series A and their mission to bring precision engineering to therapeutics.

Introducing Amplify Bio's new advisors
Welcoming Hani Goodarzi, Michael Fischbach, Steve Holtzman, and Patrick Loerch to the Amplify Bio team.

Infinitopes: Preventing Cancer Recurrence
Roughly 70-90% of cancer mortality can be attributed to metastasis. Infinitopes is one of our best shots at solving it.

Cancer's 95% problem
What if you could turn finding cancer drugs into a data problem?



















